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The 2006 death of Dale Lloyd, an athlete at Rice University 
who carried the sickle cell trait (SCT), led to major revisions 
of the SCT screening policy of the National Collegiate 
Athletic Association (NCAA). Lloyd’s collapse at football 
practice and subsequent death were attributed to 
complications from SCT. Lloyd’s family sued the NCAA 
and Rice University. One of the stipulations of the resulting 
settlement was that the NCAA require SCT testing for all 
Division I athletes. Therefore, in August 2010, the NCAA 
implemented a policy mandating SCT testing for all 
Division I collegiate athletes. Subsequently, all Division II-
III athletes were also compelled to undergo SCT testing. 
Routine SCT testing is now part of the pre-participation 
medical exam that all NCAA athletes complete, except in 
cases where the athlete provides results of a prior SCT 
screening test or signs a written release (Hosick, 2010). 
 
There is a distinction between the SCT and sickle cell 
disease (SCD). The SCD and SCT primarily affect African 
Americans, but not exclusively. Between 80,000 and 
100,000 Americans have SCD (Brousseau et al, 2010; 
Hassell, 2010). SCD occurs in about one in every 500 
African-American births, compared to 1 in every 36,000 
Hispanic-American births, and 1 in every 100,000 
Caucasian births (National Heart Lung and Blood Institute 
(NHLBI), 2014). People with SCD may experience episodes 
of sudden pain throughout the body, severe anemia, eye 
problems, and organ failure (NHLBI, 2014). Therefore, 
SCD can cause substantial physical, social, and financial 
burdens and is associated with lower life expectancy in 
sufferers (Elmariah, 2014).  SCT, however, is generally 
regarded as a benign condition. People with SCT do not 
typically experience the anemia or joint pains experienced 
by those with SCD, and usually have a normal life 
expectancy.  About two million Americans, or one in 12 
African Americans, carry the SCT (NHLBI, 2014). 
 
Complications of SCT 
Medical complications from the SCT are rare.  However, it 
has been associated with hematuria (blood in the urine), 
hyposthenuria (inability to concentrate urine), splenic 
infarction (tissue death due to lack of oxygen) at high 
altitudes, and death from extreme exertion, as in the Lloyd 
case (Harrelson, 1995; Kark, 1987; Kerle, 1996). Harmon 
et al (2012) analyzed NCAA data from 2004-08 and found 
RESEARCH AND PRACTICE 
ABSTRACT 
 
Background: In August 2010, the National Collegiate Athletic Association (NCAA) implemented a policy mandating sickle 
cell trait (SCT) testing for all Division I collegiate athletes. Subsequently, all Division II-III athletes were also compelled to 
undergo SCT testing. This decision has met with controversy among healthcare providers, researchers, and sickle cell 
advocates. However, there is little information concerning the athletes’ perspective of this policy.  The purpose of this paper is 
to report the findings of a qualitative study that explored college athletes’ perceptions of sickle cell trait SCT, NCAA policies 
on SCT testing, and potential implications of SCT screening.  
 
Methods: The participants were eighteen male and female athletes (ages 18-24), members of NCAA-governed teams who 
were on the study campus from April-August 2010. Athletes participated in focus groups that gathered their perceptions of the 
SCT, the NCAA SCT policy, and social and behavioral implications of a SCT diagnosis.  
 
Results: Athletes lacked knowledge of the SCT and the implications of a positive screening test result, desired health 
education about SCT, were conflicted about sharing health information, and feared loss of playing time if found to carry the 
SCT.  
 
Conclusions: The study revealed athletes’ perceptions of the SCT and mandated NCAA SCT testing that should be addressed 
by college health professionals.  
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that SCT carriers were 37 times more likely to die from 
exertion than athletes without the SCT.  Despite these 
findings, there continues to be much debate in the scientific 
community surrounding the link between the SCT and 
exercise-related morbidity and sudden death (Thompson, 
2013). The clinical manifestations of the SCT as they relate 
to athletic participation have been the main focus of 
scholarship on the NCAA policy. However, evidence-based 
information on the social and behavioral aspects of the 
policy is lacking. Nevertheless, the physiological aspects of 
trait have been described (Connes, 2008; Eichner, 2011; 
Harmon, 2012; Schommer, 2012, Thompson, 2013).  The 
focus this paper is on the historical facets of SCT screening 
and the social and behavioral implications of screening from 
the points of view of athletes. 
 
Opposition to the SCT Screening Policy of the NCAA 
Literature concerning the mandatory SCT screening policy 
of the NCAA constructs it as a social and clinical 
experiment (Bonham, 2012), notes the inconsistency of 
delivery of SCT health education, addresses the possibility 
of discrimination towards athletes who are SCT 
carriers (Grant, 2011) and raises concerns about protection 
of  individual rights of athletes (Jordan, 2011). Many 
suggest that scientific evidence to support the policy’s 
underlying assumptions of cause and effect between the 
SCT and death is lacking (Jordan, 2011).  
 
History of SCT screening 
The lack of scientific evidence linking the SCT to morbidity 
and sudden death is a critique of the NCAA policy, but 
discomfort with the policy is also grounded in the troubled 
history of SCT screening. The history of sickle cell disease 
and trait (SCD/T) screening has been fraught with claims of 
discrimination, genocide, and general skepticism, especially 
among African Americans. The Sickle Cell Disease Control 
Act of 1972 (Hill, 1994) was designed to increase 
knowledge and awareness of SCD among African 
Americans and other ethnic groups. However, it also 
provoked racialized controversies (Hill, 1994; Wailoo, 
2001). Further criticisms of early sickle cell screening 
programs included their lack of sensitivity to issues of race, 
controversy surrounding the accuracy and validity of the 
early screening tests, and inadequate protection of patients’ 
rights (Markel, 1992). SCT carriers have also been subject 
to discrimination. For example, carriers have been denied 
employment after a positive test (United States Congress, 
1990) and, prior to 1981, the United States Air Force 
Academy excluded African-Americans with sickle cell trait 
because of concerns over service-connected disability 
(Scott, 1982). Further, potential links between the SCT and 
lost athletic opportunity (via reduced playing time) raises 
concerns about discrimination, since African Americans 
carry the SCT disproportionately to their Caucasian and 
Latino peers.  
 
The analysis presented here is pertinent to collegiate athletic 
trainers, coaches, physicians, and health educators (hereafter 
referred to as “college health professionals”). These 
professionals should be aware of the social and behavioral 
implications of this policy when implementing SCT 
screening practices on their respective campuses. While the 
existing literature examines SCT testing from the 
perspectives of professional organizations (APHA, SCDAA, 
and ASPHO), pediatricians (Koopmans, 2011) researchers 
(Bonham, 2010; Grant, 2011; Jordan, 2011; Thompson, 
2013), and sports medicine providers (Acharya, 2011), the 
perspectives of athletes - the individuals directly affected by 
this policy - have not been adequately examined. This 
article moves beyond the dominant emphasis on clinical 
manifestations of the SCT in athletics by focusing on the 
social and behavioral implications of SCT testing for NCAA 
athletes.  
 
Between April and August 2010, a mixed methods 
study (Lawrence, 2010) was conducted at a mid-sized 
university in the southern United States to explore college 
athletes’ perceptions of SCT and NCAA policies on SCT 
testing and the potential implications of NCAA SCT 
screening policies. The quantitative portion of the study 
surveyed 259 athletes and examined race- and gender-
related differences in athletes’ perceptions regarding SCT 
risk and level of concern about lost playing time following 
diagnosis. These results are reported elsewhere (Lawrence 
& Shah, 2014). Following the quantitative portion, the 
qualitative portion of the study was implemented to examine 
perceptions held by athletes. This paper reports the findings 
of the qualitative portion, which used focus groups to 
explore college athletes’ perceptions of the SCT and NCAA 
policies on SCT testing. These perceptions are informative 
of the social context of implementation of SCT screening in 




The three prominent research questions were:   
 
1) What are the perceptions of collegiate athletes of the 
SCT and NCAA SCT testing? 
2) Do perceptions of collegiate athletes of the SCT and 
NCAA SCT testing differ by race? 
3) What are the implications of an SCT diagnosis from 
the perspectives of athletes?   
 
The theoretical framework for this study drew insights from 
Critical Race Theory (CRT) (Delgado, 2001) and the Health 
Belief Model (Strecher & Rosenstock, 1996). CRT is a 
conceptual lens used to evaluate racism and distribution of 
power and privilege amongst racial groups within 
institutions and society. The basic tenets of CRT posit: 
1) racism is normal (that is, a part of the everyday lives of 
persons of color); 2) interest convergence (i.e., because 
racism advances the interests of the majority (materially) 
and the minority (physically) there is little incentive to 
eradicate it); 3) race is a social construction (society and 
culture influence mental constructs and stereotypes around 
race); and 4) differential racism (each race has a unique 
history). In this context, CRT aims to provide minorities a 
“voice” in both academic and public arenas (Delgado & 
Stefancic, 2001).  For our purposes, CRT draws attention to 
how race may affect athletes’ perceptions of the SCT and 
SCT screening, and allows location of some of the 
individual perceptions highlighted by this study in a larger 
context of (American) institutionalized racism.  
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The Health Belief Model (HBM) is a value-expectancy 
theory that helps predict why individuals take action (or not) 
to perform specific health behaviors, such as preventive 
screening for certain illnesses or conditions (Strecher & 
Rosenstock, 1996). Constructs of the HBM were used to 
determine perceptions about susceptibility, severity, 
benefits, and barriers to SCT screening and to determine 
perceptions of athletes regarding SCT testing.  
 
The study was conducted from April-August 2010 at a co-
educational university in the southern United States. At the 
time of the study, nearly 20,000 students were enrolled: 
29.9% (4,981) were minorities, with 22.1% (3,874 students) 
being African American. Approximately 270 athletes were 
on the  intercollegiate athletic teams of the university.  The 
athletic program mandated SCT screening for all of its 
student athletes, regardless of ethnicity, beginning in 2009 
(prior to the NCAA’s mandatory SCT screening policy and 
the implementation date of this study).  The views of 
athletes about both voluntary and mandatory SCT testing 
were elicited.     
 
Eligibility requirements included being a male or female 
athlete 18 years of age or older and a current member of an 
NCAA-governed athletic team on the study campus. All 
athletes who met these requirements were eligible to 
participate in the focus groups regardless of prior screening 
history or SCT status. Athletes to participate in focus groups 
were recruited by strength and conditioning coaches. The 
study coordinator developed a recruitment guide that was 
given to coaches to aid in athlete recruitment. A purposeful 
sample of participants was sought to maximize variation in 
perspective by race, sex, and sport. The university’s 
Institutional Review Board (IRB) approved the study.  
 
A focus group guide was used to structure the discussions. 
Initial questions allowed participants to reflect on their 
general experiences as college athletes. The HBM provided 
the framework for the next set of questions, which asked 
athletes about their knowledge of the SCT, their perceptions 
of voluntary and mandatory SCT testing, and their 
perceptions of the implications if they were found to carry 
the SCT during a pre-participation health screening. Since 
the SCT primarily affects African Americans, the athletes’ 
perceptions of race relations and racism on campus and in 
athletics were also discussed. Critical Race 
Theory (Delgado & Stefancic, 2001) informed the design of 
this group of questions.  
 
Each focus group lasted for about one hour and was held in 
the evenings in a meeting room that was used specifically 
for athletics programs. The focus group facilitator 
administered an informed consent process to the 
participants. Because the SCT primarily affects African 
Americans, focus groups were separated by self-identified 
race to provide a means to compare within- and between- 
group differences in responses. Three focus groups 
involving 18 athletes were conducted. Table 1 illustrates the 
composition of each of the focus groups.  
 
 Table 1: Focus Group Demographics                                                                                                 s                
Note:  FB=Football; VB=Volleyball; CC=Cross Country; BB=Basketball 
 
Focus group 1 consisted of athletes who self-identified as 
Caucasian, and focus group 2 consisted of athletes who self-
identified as African American. Focus group 3 was a mixed-
race group that consisted of individuals in groups 1 and 2 
who volunteered to return for a follow-up group. The 
purpose of this group was to gain clarity on responses given 
in the contexts of groups 1 and 2, and to assess group 
dynamics and variation in response to questions, especially 
those concerning race, when the group was of mixed race. 
Participants were given an opportunity to contribute other 
information or opinions before each focus group concluded. 
No incentives were used to recruit the athletes because it is 
against NCAA policy to incentivize college athletes.   
 
All focus group discussions were audio recorded. 
Recordings were transcribed verbatim, coded, and analyzed 
thematically using Atlas.ti 6.2 qualitative data analysis 
software (Atlas.ti, 2010). A codebook, developed a priori, 
employed constructs drawn from the study’s theoretical 
framework. Three researchers coded the transcripts and met 
periodically to resolve any discrepancies. To assure data 
integrity (reliability and validity), coder reliability 
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techniques developed by Kirk and Miller (1986) were 
implemented.  Lincoln and Guba’s (1985) trustworthiness 
criteria were used to evaluate the credibility of study 
findings. To protect privacy of participants, all data were de-




Analysis of focus group transcripts, digital recordings, and 
field notes yielded various themes related to SCT policy and 
testing, control of health information and the racial climate 
in college sports at the university. Themes identified 
included: 1) misconceptions of the SCT; 2) positive views 
of mandatory SCT testing; 3) desire for health education 
regarding the SCT; 4) race issues in campus athletics; and 5) 
communication conflict and fear of lost playing time. Each 
of these themes is explored below. 
 
Misconceptions of the SCT 
Athletes had misconceptions of the SCT and were unaware 
of its history as it relates to race. Although they knew that 
African Americans were more likely to be carriers, much of 
their knowledge about the SCT was general in nature. For 
example, athletes said, “It’s predominately in African 
Americans,” or “It’s something in the blood.” Athletes were 
uncertain about medical risks or consequences of having the 
trait, although they knew that athletes with the SCT might 
get “winded quicker.” One athlete stated, “It’s not as serious 
as the actual disease.” Athletes demonstrated basic 
understanding of the genetic inheritance pattern of the trait 
by making statements such as, “It’s not always passed down 
through the generations. You know your father might have 
it [SCT], but that doesn’t mean you will have it...and even 
both your parents might have it.” Many statements about the 
SCT reflected exposure to education about SCD/T at some 
point. However, these statements illustrate the vagueness of 
knowledge about the SCT.  Athletes made comments such 
as, “…their blood cells are like split in half or have holes in 
them or something,” likely in reference to the sickling of 
blood cells in SCD. Other statements hinted at the 
distinction between the SCT and SCD, though not 
completely accurately. For example, “…with [the sickle 
cell] trait, you have the potential to carry the disease,” and 
“If you’re a carrier, you have spots of it throughout your 
body and it’s not necessarily full-on spread.” Athletes also 
had the misconception that SCD/T only occurred in African 
Americans and agreed that “Caucasians can’t get it.” 
 
Positive Views of Mandatory SCT Testing 
Although athletes held misconceptions of the SCT, they 
understood the rationale for the mandatory SCT screening 
policy and thought that greater awareness of SCT, both 
generally and individually, was a good thing. When asked 
how they felt about the policy, participants overwhelmingly 
responded, “It’s good!” or, “It’s smart.”  
 
Other comments expressed a sense of indifference about the 
policy, viewing it simply as, “something else we gotta do 
for the NCAA. It’s one box to check among many before 
you can get along to the business of playing your sport.” An 
athlete further explained why athletes might be passive 
about SCT testing:   
 
“I don’t think it affects a lot of athletes 
because they are just gonna look at it as 
something else we gotta do for the 
NCAA. So let’s go on and get it done and 
go on about our business.  ‘Cause in the 
pre-season you gotta do all this and that, 
fill out this and that…so you’re like 
alright…something else we gotta do.  
Let’s get it done and get the season on 
with.” 
 
Since athletes are accustomed to meeting NCAA mandates, 
they did not perceive the NCAA SCT screening policy as 
different from any of the other guidelines or physical 
examinations to which they had to consent to play collegiate 
athletics. Athletes were willing to do whatever it took to 
play their respective sports—even if it meant having a 
genetic test.   
 
Health Education 
Athletes were ambivalent about SCT testing in the pre-
participation sports physical.  However, they also desired 
health education related to the SCT, and feedback following 
their SCT screening. In reflecting on the pre-participation 
sports physical process, athletes stated that they wished to 
learn about the screening tests as well as the results of the 
pre-participation physical.  The following quote illustrates 
the dominant sentiment among athletes regarding the need 
for health information:  
 
“People actually need to know what 
they’re getting their blood taken for 
instead of saying…well you probably 
don’t have it but we gotta do it anyway 
type of thing.  That’s the biggest thing. 
Nobody really knew [what we were being 
tested for].  We just kinda did it.” 
 
Athletes approached the pre-participation physical as 
something to get out of the way and viewed themselves as, 
‘going through the motions.’ Nonetheless, many suggested 
that they wished to to be more knowledgeable about the 
SCT, and the potential consequences of the examination. 
This desire, however, was tempered by their anxiety around 
learning more about the SCT and their potential personal 
risk:  
 
“I think they should really tell you what 
you are being tested for because last year 
when they told me I had to get a sickle 
cell test, I was like ‘what am I gonna 
do’?...and they were like ‘mostly black 
people get it, and I was like…oh ok…well 
I’m good then…I don’t need to worry 
about anything.’ But they tell you what it 
is and tell you the symptoms and you’re 
like ‘oh that could be [bad]’!” 
 
Perceptions of SCT and NCAA SCT Testing  
Race and discrimination were pertinent to the discussions 
with athletes since the SCT, and therefore the consequences 
J Ga Public Health Assoc (2015) Vol. 5, No. 2
GPHA www.jgpha.com        180 Georgia Public Health Association
of positive SCT testing, primarily affects African 
Americans.  Athletes expressed no knowledge of the 
negative history of SCT testing as it relates to race.  
Regarding the role of race on their sports teams, African 
American athletes thought they would not experience 
discrimination as long as they offered value to the team:  
 
“I say no they’re [African American and 
Caucasian athletes] not treated different 
because it’s on the basis of whether or not 
you’re good at your sport. If you play 
football and you’re African American or 
Caucasian and you’re good at your sport 
and you’re on billboards and stuff they are 
gonna treat you the same. It’s just like on 
a level of how good you are.”  
 
Although African American athletes did not perceive blatant 
racism, they recognized that race played a role in the 
circulation of stereotypes around specific roles in their 
sports. To illustrate this point, an African American athlete 
suggested, “You don’t see too many Caucasian defensive 
backs in football at any level. That’s just how it is. That’s 
how society has the sport set up.”  
 
Therefore, African American participants generally 
perceived being black in college athletics not as a hindrance 
or source of discrimination, but as a protective factor. They 
felt that they, as African Americans, were essential to 
college sports and that the coaches and athletic directors 
were well aware of that fact. As such, a diagnosis of the 
SCT was not perceived as something that would keep them 
from playing. On the other hand, athletes had limited 
awareness of the SCT as a health or a racial issue, which 
may have limited their ability to evaluate its potential 
ramifications. 
 
Communication Conflict and Fear of Lost Playing Time 
When injuries and health problems arose, athletes weighed 
carefully what information to disclose to coaches and 
trainers, to the degree that they were able. Athletes shared 
that they were not always forthcoming about their health 
with coaches for fear that revealing health problems would 
result in lost playing time. They were conflicted on this 
point, and recognized that there were many good reasons to 
fully disclose information to coaches and trainers. However, 
athletes overwhelmingly agreed that they would receive less 
playing time if coaches knew of health issues and that this 
was an important consideration when they decided what 
information to share: 
 
“When I came in [to the athletic program] 
I had knee problems, I had ankle 
problems, I had shoulder problems and I 
knew that but they [coaches and athletic 
trainers] didn’t know. I’m not going to 
volunteer my injuries.”  
 
 Playing on a team at the Division I NCAA level was a point 
of pride and realized ambition for most and, in many cases, 
was also a source of funding for college studies. As such, 
exclusion from play was a severe consequence viewed with 
substantial anxiety by the athletes. When asked explicitly 
about the potential consequences of a positive SCT test, 
athletes agreed that a positive test could result in lost 
playing time, a severe consequence from their vantage 
point. In this vein, athletes held negative perceptions of the 
SCT, not because of the clinical implications of the disease, 
but because of the perceived effect a diagnosis might have 
on playing time. When asked how they would feel if they 
were diagnosed with the SCT, participants overwhelmingly 
responded, “Screwed!” In addition, athletes speculated that 
they might be viewed differently if found to carry the SCT. 
 
“I would feel upset because that means 
that I would be looked at differently and 
even though I may say I’m okay…if the 
trainer doesn’t think I’m okay…I still 
have to sit out…and just sitting out, you 
feel like you’re useless sometimes.”  
 
The fear of being useless and having to sit out during events 
was strong. In addition, athletes acknowledged the loss of 
control that occurs when a positive SCT test is shared with 




The purpose of this study was to explore college athletes’ 
perceptions of the SCT and NCAA SCT testing policies in 
order to determine potential implications of SCT screening 
in the context of organized sports.  
 
Most athletes held misconceptions about the SCT. This 
result is not surprising given that there is a generally low 
level of awareness about the SCT among the general 
population in the U.S. (Treadwell, 2006) and is consistent 
with the findings of other studies focused on similar 
populations. Ogamdi (1994) found that, like the athletes in 
our sample, the college students in their study incorrectly 
believed that the SCT can become SCD. This lack of 
knowledge about the SCT found among college athletes has 
implications for the structure of SCT-related policies 
designed for college athletes. For example, the incorrect 
belief that only Black athletes may be affected by the SCT 
may lead non-Black athletes to make uninformed decisions 
about SCT testing, or neglect to seek out education and 
information about the SCT.  
 
The present results suggested that many athletes were 
unaware that they had been tested for the SCT because it 
was masked by the extensive routine pre-participation sports 
physical. In addition, athletes had not considered the 
potential implications of a positive SCT result either inside 
or outside of the context of sport. These findings are 
relevant since SCT screening is not an inherently benign 
activity, especially in the absence of adequate education on 
the SCT. Given the potential racial, social, financial, and 
emotional consequences for athletes who test positive for 
the SCT, education and counseling should be incorporated 
into the testing process (Treadwell, 2006). Additional 
support should be offered to those who test positive for the 
SCT. Quick (2012) showed that SCT carriers were unaware 
of exertional sickling, making them less likely to take 
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precautions to minimize risk. These findings also highlight 
ethical issues regarding informed consent, autonomy, and 
privacy of health information that have not been adequately 
discussed in this context. 
 
Consistent with the findings of another study (Schroeder, 
2010), athletes felt pressure to restrict communication of 
health issues, as they were able, to protect playing time. 
Concealing health information can negatively impact health 
of athletes.  An athlete with the SCT, for example, should be 
forthcoming about any symptoms that they may feel during 
heavy physical exertion in order to receive extra recovery 
time from coaches or trainers. Interventions designed to 
protect athletes from health hazards often rely on self-report 
of early signs of trouble; their effectiveness is undercut by 
pressure felt by athletes to stay on the field. On the other 
hand, if athletes with the SCT are limited by coaches and 
trainers more than necessary, this has a range of negative 
consequences for the athlete.   
 
Study participants identified race-related stereotypes within 
athletics (i.e., “Black girls sprint, White girls run long 
distance”). Notably, though, being African American was 
seen as a protective factor for some of the African American 
athletes, who considered that they were “needed” in their 
sport. They felt that this was also true even for those who 
might be diagnosed with the SCT. These findings are in 
contrast to those of another study (Harper, 2009) which 
found that African American athletes believed that they 
were treated differently on campus and in athletics and also 
felt that they had less opportunity to rise to leadership 
positions within athletics. Although study participants 
recognized race-related stereotypes within athletics, they 
seemed completely unaware of the history of race and 
racialized notions as they pertain to SCT screening. Since 
SCT primarily affects African Americans, it is imperative 
that college health professionals be cognizant of these race 
related stereotypes and anticipate how they might affect 
athletes’ decisions regarding testing and perceptions of the 




In sum, the issue of mandatory SCT testing in the NCAA is 
fraught with challenges and paradoxes, and there is need for 
further discussion on the part of athletes, coaches, trainers, 
and officials. These findings set forth possible implications 
of NCAA-mandated SCT testing, as expressed in the words 
of Division 1 NCAA athletes at a southern university.  
 
Study limitations include the small number of participants, 
due to limited availability. Nevertheless, various 
perspectives by sex, sport, and race were obtained, and 
study themes were reiterated across focus groups. Focus 
groups are limited by their social and normative nature and 
their low capacity to assess correlation and causation. The 
study was mixed-method, however, and related quantitative 
findings are reported elsewhere (Lawrence & Shah, 2014). 
The findings may not transfer to universities with different 
athletic cultures and student demographics. While results 
are not necessarily generalizable to all NCAA governed 
athletics programs, they do provide insight into issues 
related to SCT screening for athletes at large Division I 
schools and highlight the need for discussions and research 
about the social and behavioral dimensions of SCT testing 
among athletes. In addition, an examination of the 
likelihood that SCT testing in the college athletic setting can 
achieve its public health goals is needed. 
 
Future studies should expand this work to include NCAA-
governed athletics programs of varying size and from 
diverse locations. More work is needed to determine the 
experiences of athletes who have tested SCT-positive as 
well as the experiences of their coaches and the athletic 
trainers who treat them. Finally, SCT screening policies and 
procedures of NCAA governed universities should be 
critically examined to ensure that athletes with the SCT are 
adequately protected from unintended discrimination. 
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